U.S. Healthtech Stock News

NasdaqGS:GLUE
NasdaqGS:GLUEBiotechs

Does Monte Rosa Therapeutics' (GLUE) Shift Into Russell Growth Indices Recast Its Biotech Risk Profile?

Monte Rosa Therapeutics, Inc. (NasdaqGS: GLUE) was recently removed from several Russell Value benchmarks and added to multiple Russell Growth benchmarks, including the Russell 2000 Growth, 2500 Growth, 3000 Growth, 3000E Growth, Small Cap Comp Growth, and Microcap Growth indices. This broad shift from Value to Growth classifications across the Russell index family highlights a change in how index providers now categorize Monte Rosa’s profile within the small-cap biotech universe. We’ll now...
NYSE:LMT
NYSE:LMTAerospace & Defense

Lockheed Martin (LMT) Leaves Russell Value Indexes, Is The Stock Still 25% Undervalued?

Lockheed Martin (LMT) has just been removed from several Russell value indexes and added to the Russell 1000 Dynamic Index. This shift can affect trading flows and short term stock volatility. See our latest analysis for Lockheed Martin. Over the past quarter, Lockheed Martin’s share price has been under pressure, with a 90 day share price return that declined 15.23% and a 30 day share price return that fell 4.35%. At the same time, the 1 year total shareholder return sits at 13.63% and the...
NYSE:HAE
NYSE:HAEMedical Equipment

Haemonetics’ Broad Russell Value Index Inclusion Might Change The Case For Investing In Haemonetics (HAE)

In late June 2026, Haemonetics Corporation (NYSE: HAE) was added to multiple Russell value-oriented and defensive benchmarks, including the Russell 2000 Value, Russell 2500 Value, Russell Small Cap Comp Value, Russell 3000 Value, and Russell 3000E Value indexes. This broad inclusion across several Russell value and defensive indexes can increase passive ownership, deepen liquidity, and reinforce Haemonetics’ positioning as a value-tilted medtech name in institutional portfolios. We’ll now...
NasdaqGS:PHVS
NasdaqGS:PHVSPharmaceuticals

Pharvaris (PHVS) Unveils Strong Phase 3 HAE Data, Is The Valuation Too Expensive?

Pharvaris (NasdaqGS:PHVS) is back in focus after presenting detailed Phase 3 and long term data for its oral deucrictibant program in hereditary angioedema at the EAACI 2026 congress in Istanbul. See our latest analysis for Pharvaris. Pharvaris shares have been gaining momentum, with a 30 day share price return of 12.77% and a 90 day share price return of 24.62%. The 1 year total shareholder return stands at 100.06%, and recent EAACI data are being viewed as a meaningful update to the...
NasdaqGS:TRMK
NasdaqGS:TRMKBanks

Trustmark (TRMK) Could Be 2% Below Fair Value As Analysts See Limited Upside

Trustmark (TRMK) drew fresh attention after its recent trading session, with the stock closing at $46.59. Investors are weighing this price against the bank’s earnings profile and longer term total return record. See our latest analysis for Trustmark. Recent trading sits within a broader upswing for Trustmark, with a 30 day share price return of 5.5% and a 90 day gain of 10.72%. The 1 year total shareholder return of 29.68% and 3 year total shareholder return of around 14x also suggest that...
NasdaqGS:NBIS
NasdaqGS:NBISSoftware

Nebius Stock And 2 AI Infrastructure Picks With Fast Growth And Insider Ownership

Fast growing stocks with high insider ownership sit at the crossroads of two powerful forces in today’s market, where AI investment, global rate decisions and shifting trade patterns are all front of mind. On one side, you have companies that analysts and management see as having strong growth potential. On the other, you have insiders who have chosen to keep significant skin in the game. This article focuses on that overlap and highlights 3 stocks from the Fast Growing Stocks With High...
NasdaqGS:SYNA
NasdaqGS:SYNASemiconductor

Microsoft Stock And 2 AI Stocks Worth Watching Now

Artificial intelligence is no longer just a tech buzzword; it is influencing everything from chip factories in Asia to cloud data centers in the US and Europe. With China’s industrial profits tied to AI investment, central banks still focused on inflation, and manufacturing and trade readings shaping sentiment, many investors are looking for focused ways to get exposure to the ChatGPT and AI trend without trawling through hundreds of stocks. This AI Stocks screener filters for companies...
NasdaqCM:WULF
NasdaqCM:WULFSoftware

TeraWulf (WULF) Is Buying Kentucky’s Muskie Data Campus For AI And HPC

TeraWulf (NasdaqCM:WULF) has agreed to acquire the Muskie Data Campus in Kentucky. The site is intended to support high-performance computing and artificial intelligence focused infrastructure. The transaction reflects TeraWulf's move into hyperscale digital infrastructure beyond its existing operations. TeraWulf, known for its digital infrastructure and computing focused business, is adding the Muskie Data Campus in Kentucky to its portfolio. For investors watching how high-power...
NYSE:AWK
NYSE:AWKWater Utilities

American Water (AWK) Lands 2026 Sustainability Honor As Water Quality Efforts Stand Out

American Water Works Company (NYSE:AWK) has been recognized among the World's Most Sustainable Companies in 2026. The company is highlighting community engagement programs and recent water quality achievements alongside this recognition. The stock most recently closed at $132.68. American Water Works Company, trading under NYSE:AWK, is drawing fresh attention after being named one of the World's Most Sustainable Companies in 2026. This recognition comes alongside recent community engagement...
NYSE:EQT
NYSE:EQTOil and Gas

EQT (EQT) Could Get A Clearer Path As FERC Speeds Pipeline Approvals

FERC has approved reforms to accelerate approvals for natural gas infrastructure projects, including pipeline upgrades. These changes are expected to ease regulatory constraints that affect companies such as NYSE:EQT, the largest U.S. natural gas producer. The reforms could influence project timelines, capital planning, and future infrastructure buildout for EQT. EQT sits at the center of the U.S. natural gas supply chain, with production volumes closely tied to the availability of...
NasdaqGS:CSCO
NasdaqGS:CSCOCommunications

Cisco Systems (CSCO) Stock After 50% YTD Surge Is There More Upside Left

If you are wondering whether Cisco Systems stock still offers value after a strong run, this article walks through what the current share price might be implying. Cisco Systems recently closed at US$113.77, with the share price down 4.8% over the past week and 5.5% over the past month, yet still up 49.6% year to date and 69.5% over the last year. These moves have put Cisco Systems firmly on many investors' watchlists, as they reassess what is already priced into the stock. The strong 3 year...
NYSE:AVTR
NYSE:AVTRLife Sciences

Avantor (AVTR) Stock After Recent Rebound And DCF Valuation Gap

If you are wondering whether Avantor stock is starting to look mispriced, its recent moves and current valuation metrics give you quite a bit to think about. The share price closed at US$10.28 recently, with a gain of 7.3% over the past week and 12.7% over the past month, even though the stock is still down 10.3% year to date and has fallen 24.0% over the past year. These price moves are set against a backdrop of ongoing attention on Avantor's position in life sciences supplies and services,...
NasdaqGS:RKLB
NasdaqGS:RKLBAerospace & Defense

Is Rocket Lab (RKLB) Quietly Redefining Its Moat With Rapid-Response Launches and NASA Contracts?

Rocket Lab recently completed its tenth dedicated Electron launch for Japan’s Synspective and broke a global rapid-response record with its VICTUS HAZE mission for the U.S. Space Force, while also winning a three-launch NASA contract for the PolSIR and TSIS-2 science missions from Launch Complex 1 in New Zealand. These back-to-back government and commercial wins highlight Rocket Lab’s shift into an integrated launch-and-space-systems provider, with mission agility and customized hardware...
NasdaqGS:BIDU
NasdaqGS:BIDUInteractive Media and Services

Baidu (BIDU) Wins Swiss Robotaxi Trial Approval, Is The AI Upside Already Priced In?

Baidu (BIDU) is back in focus after its Apollo Go unit and Swiss Post’s PostBus received approval for Level 4 autonomous driving trials in Switzerland, marking the company’s first self driving tests in Europe. See our latest analysis for Baidu. The autonomous driving approval lands at a time when Baidu’s share price has been under pressure, with a 30 day share price return of down 23% and a year to date share price return of down 31%, even as the 1 year total shareholder return is 21%. This...
NasdaqGM:LNTH
NasdaqGM:LNTHMedical Equipment

Lantheus Holdings (LNTH) New Product Narrative Keeps Valuation Questions In Focus

Lantheus Holdings (LNTH) has drawn fresh attention after recent share price moves, with the stock closing at $109.80. Investors are reassessing what the company’s diagnostics and radiopharmaceutical portfolio implies for current valuation. See our latest analysis for Lantheus Holdings. The recent move in Lantheus Holdings fits into a strong run, with a 30 day share price return of 10.57% and year to date share price return of 63.22%, while the 5 year total shareholder return of 285.13% points...
NYSE:MHK
NYSE:MHKConsumer Durables

Is Mohawk Industries’ (MHK) CEO Succession Plan Quietly Reframing Its Margin Resilience Story?

Earlier this week, Wells Fargo expressed renewed confidence in Mohawk Industries after the flooring manufacturer outlined a CEO succession plan and continued restructuring aimed at improving operational margins. The combination of leadership transition planning and ongoing cost-efficiency measures has become a central focus for investors reassessing Mohawk’s longer-term prospects. Next, we’ll explore how Mohawk’s CEO succession planning could influence its investment narrative around margin...
NasdaqGS:CRWV
NasdaqGS:CRWVIT

CoreWeave Stock And 2 US AI Infrastructure Picks Investors Should Watch

US technology stocks are stepping into a busy stretch, with the country’s 250th anniversary celebrations, Alphabet’s entry into the Dow Jones Industrial Average, fresh tech IPOs, the June jobs report, and central bank focus on AI all competing for attention. Together, these events could shift how money moves across large US tech companies, from long standing giants like Alphabet to relatively recent listings. This article walks through 3 US Technology Sector Stocks from the screener that...
NYSE:OGE
NYSE:OGEElectric Utilities

How OGE’s Upsized Revolving Credit Facilities and Longer Tenor Will Impact OGE Energy (OGE) Investors

On June 12, 2026, OGE Energy Corp. and subsidiary OG&E entered into second amended and restated unsecured five-year revolving credit agreements, each upsized to US$650 million and extendable to 2031, replacing their prior US$550 million facilities. The expanded, ratings-linked facilities enhance liquidity and refinancing flexibility across the group, potentially supporting future capital needs such as infrastructure investments, acquisitions, and commercial paper back-up. Next, we’ll examine...
NYSE:FG
NYSE:FGInsurance

F&G Annuities & Life (FG) Rejigs Leadership As Valuation Questions Come Into Focus

F&G Annuities & Life (FG) stock is in focus after the company announced a leadership transition, with CEO Chris Blunt set to retire and President and CFO Conor Murphy moving into the CEO and President roles. See our latest analysis for F&G Annuities & Life. At a share price of $27.02, F&G Annuities & Life has seen a 1-day share price return of 2.0% following the CEO and CFO succession news, although its year to date share price return is down 10.05% and its 1-year total shareholder return is...
NasdaqGS:MBLY
NasdaqGS:MBLYAuto Components

Mobileye Global (MBLY) Eyes Robotaxi Service, Is The Stock Trading At A Discount?

Mobileye Global (MBLY) has outlined plans to move beyond supplying autonomous driving technology and into running its own robotaxi service, with a fully owned ride hailing business targeted to launch in a U.S. city in 2027. See our latest analysis for Mobileye Global. Despite the new robotaxi initiative, Mobileye Global’s share price has fallen 24.47% over the past month and is down 30.45% year to date. The 1 year total shareholder return has declined 57.42%, suggesting recent enthusiasm has...
NasdaqGS:EEFT
NasdaqGS:EEFTDiversified Financial

Euronet Worldwide (EEFT) Leans On Digital Payments Growth, Is The Stock Still Cheap?

Euronet Worldwide (EEFT) is drawing attention after recent trading left the stock around $70.43. This is prompting investors to recheck its fundamentals, recent share performance over the past month and past 3 months, and valuation signals. See our latest analysis for Euronet Worldwide. Recent trading has been choppy for Euronet Worldwide, with a 5.03% 1 day share price return and a 6.97% 7 day share price return. However, the 1 year total shareholder return is down 30.84%, indicating that...
NYSE:CPT
NYSE:CPTResidential REITs

Is Camden Property Trust’s (CPT) Steady Dividend a Sign of Resilience or Capital Allocation Caution?

Earlier this month, Camden Property Trust’s Board of Trust Managers declared a second-quarter cash dividend of US$1.06 per share, payable on July 17, 2026 to shareholders of record as of June 30, 2026. This dividend affirmation underscores management’s focus on cash returns to investors while contending with elevated apartment supply, softer rents, and higher debt. Now we’ll examine how sustaining this US$1.06 dividend aligns with Camden’s capital recycling, Sunbelt exposure, and overall...
NasdaqGS:ZG
NasdaqGS:ZGReal Estate

Zillow Group (ZG) Launches A New Digital Hub On Undervalued Growth Narrative

Zillow Group (ZG) is rolling out a personalized home buying and selling hub just as average 30 year mortgage rates in its marketplace slip to 6.17%, linking new digital tools with slightly easier financing conditions. See our latest analysis for Zillow Group. Zillow Group's recent product launches come at a time when the stock has a 1 day share price return of 7.0%, but the 1 year total shareholder return is down 54.28%, pointing to short term momentum after a prolonged period of weaker...
NasdaqGM:HELP
NasdaqGM:HELPPharmaceuticals

Cybin (HELP) As Phase 3 Enrollment Progresses, The Undervalued Narrative Holds

Cybin (HELP) is drawing fresh attention after reporting that enrollment in its APPROACH Phase 3 trial for HLP003 in major depressive disorder has surpassed 86%, a key marker in its broader PARADIGM program. See our latest analysis for Cybin. The recent APPROACH trial update comes after a sharp short term rebound in Cybin's 1 week and 1 month share price returns of 38.76% and 42.42% respectively. This is set against a year to date share price return that is still down 21.74% and a 5 year total...